Don't Let AstraZeneca's Oncology Program Slip Past Your Watchlist Seeking Alpha, 09 May 2017 AstraZeneca PLC (NYSE: AZN ) is a $70 billion market cap multinational pharmaceutical and biopharmaceutical company.